Biopico Systems, headquartered in Irvine, US, is dedicated to revolutionizing drug discovery and development through its advanced multi-organ systems. The company's core mission is to enhance the efficiency and accuracy of pharmacological research by providing innovative solutions such as the OrganRX™ System. This system offers a passive gravity-driven unidirectional shear flow to multi-organ cultures, facilitating comprehensive pharmacology, mechanistic studies, safety assessments, and pharmacokinetics. Biopico's market focus includes pharmaceutical companies and research institutions seeking cutting-edge tools for drug development.

Notable figures affiliated with Biopico Systems include leading researchers and industry experts who contribute to its pioneering efforts. The company has attracted significant investment from venture capital firms specializing in biotech innovations. Key achievements include the successful development and deployment of the OrganRX™ System, which has garnered attention for its potential to streamline drug discovery processes. Overall, Biopico Systems has made a substantial impact on the pharmaceutical industry by providing robust, reliable tools that enhance the precision and effectiveness of drug development.